Yimin Mao
- Hepatology top 5%
- Liver Disease and Transplantation 4
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management 8
-
- Pulmonary Hypertension Research and Treatments 12
- Chronic Obstructive Pulmonary Disease (COPD) Research 9
- Respiratory Support and Mechanisms 3
-
- Cardiovascular Function and Risk Factors 3
-
- Liver Disease Diagnosis and Treatment 3
- Acute Ischemic Stroke Management 3
- Co-authors
- Xiaofang LiZhi‐Cheng JingXin JiangYingying HaoWenhui WuYuanqiang ZhangAiping CaoLungen Lu
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Yimin Mao
45 papers receiving 716 citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Hepatology 196
- Internal Medicine 57
- Pulmonary and Respiratory Medicine 249
- Molecular Medicine 27
- Cancer Research 79
Countries citing papers authored by Yimin Mao
This map shows the geographic impact of Yimin Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yimin Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yimin Mao more than expected).
Fields of papers citing papers by Yimin Mao
This network shows the impact of papers produced by Yimin Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yimin Mao. The network helps show where Yimin Mao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yimin Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 2 | |
| 9 | Pembrolizumab Versus Placebo as Second-Line Therapy in Patients From Asia With Advanced Hepatocellular Carcinoma: A Randomized, Double-Blind, Phase III Trialbreakdown → | 2022 | 127 |
| 10 | 2022 | 2 | |
| 11 | 2022 | 9 | |
| 12 | 2020 | 47 | |
| 13 | 2020 | 11 | |
| 14 | 2019 | 23 | |
| 15 | 2018 | 90 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 15 | |
| 18 | 2013 | 2 | |
| 19 | Expression of Mucin MUC5AC in Rats with Asthma and Mechanisms of Anti-inflammatory Effects of Erythromycin | 2007 | 1 |
| 20 | [The inhibitory effect of oxymatrine on hepatitis C virus in vitro]. | 2001 | 19 |
About Yimin Mao
Yimin Mao is a scholar working on Internal Medicine, Microbiology and Hepatology, having authored 52 papers that have together received 729 indexed citations. Recurring topics across this work include Pulmonary Hypertension Research and Treatments (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Venous Thromboembolism Diagnosis and Management (8 papers), Liver Disease and Transplantation (4 papers), Respiratory Support and Mechanisms (3 papers), Cardiovascular Function and Risk Factors (3 papers), Liver Disease Diagnosis and Treatment (3 papers) and Acute Ischemic Stroke Management (3 papers). The work is most often cited by research in Hepatology (196 citations), Internal Medicine (57 citations) and Pulmonary and Respiratory Medicine (249 citations). Yimin Mao has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Xiaofang Li, Zhi‐Cheng Jing, Xin Jiang, Yingying Hao, Wenhui Wu, Yuanqiang Zhang, Aiping Cao, Lungen Lu, Kai Sun and Xue Zhang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.